Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
April 30, 2018
Kuros Biosciences Reports Full-Year 2017 Results
SCHLIEREN (Zurich), Switzerland, April 30, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) reported today its Full-Year 2017 Results, and the publication of its annual report. ...
April 30, 2018
Prometic Reports Positive Clinical Data from its Intravenous Immunoglobulin (IVIG) Pivotal Phase 3 Tria
LAVAL, QC , April 30, 2018 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic)  today announced positive clinical data from its pivotal IVIG phase 3 ...
April 30, 2018
BioDelivery Sciences to Host Conference Call and Webcast Reporting First Quarter 2018 Financial Results on Thursday, May 10
RALEIGH, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
April 30, 2018
ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB
LEIDEN, the Netherlands, April 30, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of transformative RNA ...
April 30, 2018
Conatus Announces Completion of Enrollment in ENCORE-PH Phase 2b Clinical Trial of Emricasan in Patients with NASH Cirrhosis and Severe Portal Hypertension
SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced the completion of enrollment in ENCORE-PH, a Phase 2b clinical trial ...
April 30, 2018
BioLife Solutions Receives $2.6 Million from Exercise of Warrants
BOTHELL, Wash., April 30, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage ...
April 30, 2018
Albireo to Present at Deutsche Bank 43rd Annual Health Care Conference
BOSTON, April 30, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
April 30, 2018
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
BOSTON, April 30, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
April 30, 2018
Pfenex to Report First Quarter 2018 Results and Provide Business Update on Thursday, May 10th
SAN DIEGO, April 30, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE American: PFNX) announced today that its first quarter 2018 financial results will be released on Thursday, ...
April 30, 2018
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
BROOKLYN, N.Y., April 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma (AZRX), (“AzurRx” or the “Company”), announced today that it intends to offer and sell shares ...
April 27, 2018
Basilea announces appointment of Chief Technology Officer and appointment of Head of Global Quality Management
Basel, Switzerland, April 27, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) reported today that as of May 1, 2018, Dr. Gerrit Hauck is appointed as Chief ...
April 27, 2018
Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018
Copenhagen, April 27, 2018 - Zealand Pharma ("Zealand") announces Q1 2018 net sales by Sanofi from Soliqua® 100/33/ Suliqua® of EUR 9.0 million/USD 11.1 million ...
April 27, 2018
Haematologica publishes Celyad THINK Study Case Report of CYAD-01 Induced Complete Remission in Relapsed/Refractory AML Patient
MONT-SAINT-GUIBERT, Belgium, April 27, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of CART-cell therapies, ...
April 27, 2018
Moberg Pharma Completes Divestment of Balmex® for $4.25 million
STOCKHOLM, April 27, 2018 /PRNewswire/ --  Moberg Pharma AB (OMX:MOB) has completed the divestment of the Balmex® brand to Randob Labs for a total consideration ...
April 27, 2018
Zogenix Announces Initial Quality of Life and Cognitive Function Data From Phase 3 Trial of ZX008 in Dravet Syndrome
EMERYVILLE, Calif., April 27, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
April 27, 2018
CorMedix Revises Timeline and Announces Changes to Lock-It-100 Study Management
BERKELEY HEIGHTS, NJ / ACCESSWIRE / April 27, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
April 27, 2018
Spring Bank Pharmaceuticals Provides Corporate Update and Reports First Quarter Financial and Operational Results
HOPKINTON, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
April 27, 2018
HTG Molecular Diagnostics to Announce First Quarter Financial Results and Host Conference Call on Thursday, May 10
TUCSON, Ariz., April 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today ...
April 26, 2018
Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome
Copenhagen, Denmark, April 26, 2018 - Zealand Pharma (Zealand) today announced receipt of the End-of-Phase 2 meeting minutes from the U.S. Food and Drug Administration ...
April 26, 2018
BioTime to Announce First Quarter 2018 Results on May 10, 2018
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will release first quarter 2018 financial ...
Page 46 of 117